Simi Valley, CA, United States of America

Jennifer Lorraine Gansert

This inventor holds 3 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Amgen Inc., Novartis Ag, Merck Sharp + Dohme Corp.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jennifer Lorraine Gansert. Retrieved from https://idiyas.com/inventor/jennifer-lorraine-gansert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Jennifer Lorraine Gansert

Introduction

Jennifer Lorraine Gansert is a prominent inventor based in Simi Valley, California. She has made significant contributions to the field of cancer therapeutics, holding a total of 3 patents. Her work focuses on developing innovative methods and combinations for treating various types of cancer.

Latest Patents

Gansert's latest patents include groundbreaking advancements in cancer treatment. One of her notable inventions is related to biomarkers for cancer therapeutics. This patent provides biomarkers useful for identifying a variety of cancers that respond to treatment with a combination therapy comprising pembrolizumab and talimogene laherparepvec. Additionally, she has developed methods for treating cancers resistant to monotherapy with pembrolizumab. Another significant patent involves a pharmaceutical combination that includes an alpha-isoform specific phosphatidylinositol 3-kinase inhibitor and an insulin-like growth factor-1 receptor (IGF1R) inhibitor. This combination aims to enhance the effectiveness of cancer treatments.

Career Highlights

Throughout her career, Jennifer has worked with leading pharmaceutical companies, including Amgen Inc. and Novartis AG. Her experience in these organizations has allowed her to contribute to cutting-edge research and development in the field of oncology.

Collaborations

Gansert has collaborated with notable professionals in her field, including Xizhong Huang and Malte Peters. These collaborations have further enriched her research and innovations in cancer therapeutics.

Conclusion

Jennifer Lorraine Gansert's contributions to cancer treatment through her patents and collaborations highlight her role as an influential inventor in the medical field. Her work continues to pave the way for advancements in cancer therapeutics, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…